CGX

Our cancer genomic testing analyzes mutations in a patient's DNA known to be associated with an increased risk of hereditary cancer. We provide a comprehensive report indicating a patient's potential susceptibility to various hereditary cancers. This testing uses the latest Next-Generation Sequencing (NGS) technology to analyze patient samples in a rapid and accurate approach.

PGX

Pharmacogenomics is the relationship between a patient's unique genetic makeup and their response to certain medications. Genetic mutations can cause either higher or lower rates of metabolism for known drugs. According to the FDA, each year, approximately 4.5 million Americans visit their doctors or the emergency room due to adverse drug reactions. Our genetic testing profile provides information on the connection between a patient's unique genetic makeup and their response to certain medications.

Genetics - Services